{"nct_id":"NCT04181827","title":"A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2020-06-12","start_date_type":"ACTUAL","primary_completion_date":"2024-05-01","primary_completion_date_type":"ACTUAL","completion_date":"2029-04-09","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JNJ"]}